Glaxosmithkline | Kapitał Własny I Rezerwy



Equity Capital And Reserves Zmiana Data
AbbVie USD 3.32B 2.71B 2024-12
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bausch Health Companies USD -1183000000 861M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 683.28M 3.7M 2025-03
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
GlaxoSmithKline GBP 14.16B 486M 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Indivior -285000000 63M 2025-03
J&J USD 78.11B 6.62B 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 42.05B 3.6B 2025-06
Pacira USD 798.54M 20.19M 2025-03
Perrigo USD 4.36B 44.6M 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Prestige Brands USD 1.83B 46.46M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Takeda JPY 6.94T 483.19B 2025-03
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03
Zoetis USD 4.66B 115M 2025-03


Glaxosmithkline Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.